• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Jessica A. Meznarich, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English, Mandarin Chinese

Dr. Meznarich received her medical degree from the University of Washington School of Medicine in Seattle, Washington. She then completed her residency in Pediatrics and fellowship in Pediatric Hematology and Oncology at the University of Utah/Primary Children’s Hospital in Salt Lake City, Utah.

She joined the faculty of the University of Utah in 2016, where she is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Her clinical and research interests are in benign hematology, hemophilia and other bleeding disorders, thrombosis and clotting disorders, and sickle cell disease.

Clinical Locations

Primary Children's Hospital

801-662-2900

100 N Mario Capecchi Drive
Salt Lake City, UT  84113

Specialties

  • Pediatric Hematology & Oncology

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

Dr. Meznarich received her medical degree from the University of Washington School of Medicine in Seattle, Washington. She then completed her residency in Pediatrics and fellowship in Pediatric Hematology and Oncology at the University of Utah/Primary Children’s Hospital in Salt Lake City, Utah.

She joined the faculty of the University of Utah in 2016, where she is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Her clinical and research interests are in benign hematology, hemophilia and other bleeding disorders, thrombosis and clotting disorders, and sickle cell disease.

Academic Locations

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

Education History

Fellowship University of Utah School of Medicine
Pediatric Hematology-Oncology
Fellow, 2016
Residency University of Utah School of Medicine
Pediatrics
Resident, 2013
Professional Medical University of Washington School of Medicine
Medicine
M.D., 2010
Undergraduate University of Washington
Biochemistry, Chemistry
B.S., 2004

Selected Publications - Journal Articles

Journal Article

  1. Niss O, Lorsbach RB, Berger M, Chonat S, McLemore M, Buchbinder D, McCavit T, Shaffer LG, Simpson J, Schwartz JH, Meznarich J, Emberesh M, Seu KG, Zhang W, Kalfa TA, CDAR consortium (2020). Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR). Blood Cells Mol Dis, 87, 102534.
  2. Bahr, TM, Knudsen, MC, Lozano-Chinga, M, Agarwal, AM, Meznarich, JA, Ohls, RK, Christensen, RD (2020). Infantile Pyknocytosis: End-Tidal CO, %Micro-R Measurements, Next-Generation Sequencing, and Transfusion Avoidance with Darbepoetin . 5.
  3. Seu KG, Trump LR, Emberesh S, Lorsbach RB, Johnson C, Meznarich J, Underhill HR, Chou ST, Sakthivel H, Nassar NN, Seu KJ, Blanc L, Zhang W, Lutzko CM, Kalfa TA (2020). VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects. Am J Hum Genet, 107(6), 1149-1156.
  4. Bahr TM, Lozano-Chinga M, Agarwal AM, Meznarich JA, Gerday E, Smoot JL, Taylor A, Christensen RD (2020). Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis. Blood Cells Mol Dis, 85, 102462.
  5. Meznarich JA, Draper L, Christensen RD, Yaish HM, Luem ND, Pysher TJ, Jung G, Nemeth E, Ganz T, Ward DM (2018). Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations. Blood Cells Mol Dis, 71, 63-66.
  6. Velinder M, Singer J, Bareyan D, Meznarich J, Tracy CM, Fulcher JM, McClellan D, Lucente H, Franklin S, Sharma S, Engel ME (2016). GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1. Biochem J, 473(19), 3355-69.
  7. Meznarich J, Miles R, Paxton CN, Afify Z (2016). Pediatric B-Cell Lymphoma With Lymphoblastic Morphology, TdT Expression, MYC Rearrangement, and Features Overlapping With Burkitt Lymphoma. Pediatr Blood Cancer, 63(5), 938-40.
  8. Meznarich J, Malchodi L, Helterline D, Ramsey SA, Bertko K, Plummer T, Plawman A, Gold E, Stempien-Otero A (2013). Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. PLoS One, 8(3), e57837.

Case Report

  1. Bahr TM, Lozano-Chinga M, Agarwal AM, Meznarich JA, Yost CC, Li P, Reading NS, Prchal JT, Christensen RD (2020). A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic Activity. Neonatology, 117(4), 532-535.

Letter

  1. Meznarich JA, Rets A, Agarwal AM, Christensen RD, Reading NS, Kuypers FA, Prchal JT (2021). Novel, de novo, beta-globin variant with decreased oxygen affinity (HBB:c.317T>A, "Hemoglobin St. George") in a healthy child with low oxygen saturations and anemia. [Letter to the editor]. Am J Hematol, 96(12), E448-E450.

Abstract

  1. Giger Seu, K, Trump, L Emberesh, S, Lorsbach, R, Johnson, C, Meznarich, J, Underhill, H, Sakthivel, H, Niss, O, Nortman, S, Blanc, L, Zhang, W, Lutzko, C, and Kalfa, T (2019). VPS4A mutations Cause a Syndrome with Dyserythropoiesis, Hemolytic Anemia, and Neurodevelopmental Delay [Abstract]. 134(Supplement 1), 339.
  2. Niss, O Lorsbach, R, Buchbinder, D, Chonat, S, McLemore, M, McCavit, T, Schwartz, J, Meznarich, J, Seu, K, Zhang, W, Kalfa, T (2019). Congenital Dyserythropoietic Anemia Type 1 Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR) [Abstract]. 134(Supplement 1), 3521.
  3. Velinder M, Singer J, Meznarich J, Theisen E, Fulcher J, Tracy C, Franklin S, Sharma S, Engel M (2015). GFI1 Snag Domain Methylation Directs LSD1 Recruitment to Control Transcription and Cell Fate Determination in Hematopoiesis [Abstract]. Blood, 126(23).

BAX 111 rVWF in Pediatrics

Description: Keywords: Principal Investigator: Jessica Meznarich

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health